Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bipin Savani

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Clinical Hematology International|November 27, 2024
Social media in medicine: a personal perspective about opportunities, challenges, and best practiceMohamad Mohty, Bipin Savani
Clinical Hematology International|October 1, 2021
Practicing Clinical Hematology During the COVID-19 Outbreak: A Challenge Like No OtherMohamad Mohty, Arnon Nagler, Bipin Savani
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2020
Improving the OddsMichael Byrne, Bipin Savani, Edward Copelan
Clinical Hematology International|October 1, 2021
<i>Clinical Hematology International</i>: Why a New Journal in Hematology?Mohamad Mohty, Arnon Nagler, Bipin Savani
Clinical Hematology International|October 1, 2021
Looking Ahead: <i>Clinical Hematology International</i> Turns OneMohamad Mohty, Arnon Nagler, Bipin Savani
British Journal of Haematology|May 26, 2021
Graft-versus-host disease risk after chimeric antigen receptor T-cell therapy: the diametric opposition of T cellsKhaled Sanber, Bipin Savani, Tania Jain
British Journal of Haematology|September 13, 2021
Treosulphan versus busulphan: pros and consPritesh Patel, Bipin Savani, Michael Byrne
Clinical Hematology International|May 31, 2024
Celebrating five years of "Hematology without Borders" by the International Academy for Clinical Hematology (IACH)Mohamad Mohty, Arnon Nagler, Bipin Savani
Clinical Hematology International|October 1, 2021
Summary of Scientific and Statistical Methods, Study Endpoints and Definitions for Observational and Registry-Based Studies in Hematopoietic Cell TransplantationAbraham S Kanate, Arnon Nagler, Bipin Savani
Therapeutic Advances in Hematology|September 14, 2018
Leveraging JAK-STAT regulation in myelofibrosis to improve outcomes with allogeneic hematopoietic stem-cell transplantMichael Byrne, Bipin Savani, Michael R Savona
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Clinical Hematology International|November 27, 2024
Social media in medicine: a personal perspective about opportunities, challenges, and best practiceMohamad Mohty, Bipin Savani
Clinical Hematology International|October 1, 2021
Practicing Clinical Hematology During the COVID-19 Outbreak: A Challenge Like No OtherMohamad Mohty, Arnon Nagler, Bipin Savani
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 18, 2020
Improving the OddsMichael Byrne, Bipin Savani, Edward Copelan
Clinical Hematology International|October 1, 2021
<i>Clinical Hematology International</i>: Why a New Journal in Hematology?Mohamad Mohty, Arnon Nagler, Bipin Savani
Clinical Hematology International|October 1, 2021
Looking Ahead: <i>Clinical Hematology International</i> Turns OneMohamad Mohty, Arnon Nagler, Bipin Savani
British Journal of Haematology|May 26, 2021
Graft-versus-host disease risk after chimeric antigen receptor T-cell therapy: the diametric opposition of T cellsKhaled Sanber, Bipin Savani, Tania Jain
British Journal of Haematology|September 13, 2021
Treosulphan versus busulphan: pros and consPritesh Patel, Bipin Savani, Michael Byrne
Clinical Hematology International|May 31, 2024
Celebrating five years of "Hematology without Borders" by the International Academy for Clinical Hematology (IACH)Mohamad Mohty, Arnon Nagler, Bipin Savani
Clinical Hematology International|October 1, 2021
Summary of Scientific and Statistical Methods, Study Endpoints and Definitions for Observational and Registry-Based Studies in Hematopoietic Cell TransplantationAbraham S Kanate, Arnon Nagler, Bipin Savani
Therapeutic Advances in Hematology|September 14, 2018
Leveraging JAK-STAT regulation in myelofibrosis to improve outcomes with allogeneic hematopoietic stem-cell transplantMichael Byrne, Bipin Savani, Michael R Savona
Pageof 12